Literature DB >> 14102000

EFFECT OF CORTICOSTEROID THERAPY ON FIBRINOLYSIS IN PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY CONDITIONS.

R CHAKRABARTI, G R FEARNLEY, E D HOCKING.   

Abstract

Entities:  

Keywords:  ADDISON'S DISEASE; ADENOMA, CHROMOPHOBE; ANEMIA, APLASTIC; ARTHRITIS, RHEUMATOID; BLOOD COAGULATION TESTS; COLITIS, ULCERATIVE; CORTICOTROPIN; CORTISONE; FIBRINOLYSIS; GERIATRICS; HEART BLOCK; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHARMACOLOGY; PREDNISONE; PURPURA

Mesh：

Substances：

Year:  1964        PMID： 14102000      PMCID： PMC1813506          DOI： 10.1136/bmj.1.5382.534

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.

Authors:  G R FEARNLEY; G BALMFORTH; E FEARNLEY
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

2.  Plasma fibrinolytic activity in cirrhosis of the liver.

Authors:  H C KWAAN; A J MCFADZEAN; J COOK
Journal:  Lancet       Date:  1956-01-21       Impact factor: 79.321

3.  Effect of ACTH on the erythrocyte-sedimentation rate and plasma-fibrinogen and serum-protein levels in normal persons.

Authors:  G R FEARNLEY; J J BUNIM
Journal:  Lancet       Date:  1951-12-15       Impact factor: 79.321
  3 in total
  6 in total

1.  A comparative analysis of warfarin and low-dose heparin as thromboembolism prophylaxis in total hip replacement patinets.

Authors:  M A Ritter
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

2.  Components of the fibrinolytic system in synovial joints. Normal bovine compared with normal and abnormal human synovial joints.

Authors:  D E Caughey; T C Highton
Journal:  Ann Rheum Dis       Date:  1967-07       Impact factor: 19.103

3.  Plasma antiheparin activity and the heparin precipitable fraction of plasma in rheumatoid arthritis.

Authors:  R C Cotton; F L Johnson
Journal:  Ann Rheum Dis       Date:  1968-09       Impact factor: 19.103

4.  Phenoformin as a fibrinolytic drug.

Authors:  G R Fearnley
Journal:  Postgrad Med J       Date:  1968-06       Impact factor: 2.401

5.  Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.

Authors:  C S Lau; M McLaren; J Hanslip; M Kerr; J J Belch
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

6.  Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.

Authors:  H Fodstad
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.